Literature DB >> 25317854

Comparison of antibody responses to HIV infection in Ugandan women infected with HIV subtypes A and D.

Andrew F Longosz1, Charles S Morrison, Pai-Lien Chen, Hilmarie H Brand, Eric Arts, Immaculate Nankya, Robert A Salata, Thomas C Quinn, Susan H Eshleman, Oliver Laeyendecker.   

Abstract

We compared the serologic response to HIV infection in Ugandan women with HIV subtype A (N=82) and D (N=32) infection using a limiting antigen avidity assay (LAg-Avidity assay); 2,614 samples were analyzed. Study participants were followed a median of 6.6 years after HIV seroconversion. Samples were classified as assay positive if they had a LAg-Avidity assay result <1.5 normalized optical density units (OD-n). Women with subtype D infection were more likely to have delayed antibody maturation. During the first 2 years after seroconversion, the mean time that women had an assay-positive result (mean duration of recent infection, MDRI) was longer for women with subtype D infection than women with subtype A infection (267.9 days, 95% CI: 231.2-308.2 vs. 167.3 days, 95% CI: 151.8-185.9 days, p<0.01). The MDRI was also longer for women with subtype D infection after excluding low viral load samples and samples from women on antiretroviral therapy (ART). Women infected for >2 years were also more likely to be misclassified as recently infected in they had subtype D infection. Women with subtype D infection were also more likely to have antibody waning compared to women with subtype A infection. These findings may be related to the higher pathogenicity of subtype D HIV infection and are relevant to use of the LAg-Avidity assay for cross-sectional HIV incidence estimation in populations where subtype D infection is prevalent.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25317854      PMCID: PMC4378664          DOI: 10.1089/AID.2014.0081

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  24 in total

Review 1.  Beyond detuning: 10 years of progress and new challenges in the development and application of assays for HIV incidence estimation.

Authors:  Michael P Busch; Christopher D Pilcher; Timothy D Mastro; John Kaldor; Gaby Vercauteren; William Rodriguez; Christine Rousseau; Thomas M Rehle; Alex Welte; Megan D Averill; Jesus M Garcia Calleja
Journal:  AIDS       Date:  2010-11-27       Impact factor: 4.177

2.  Impact of HIV subtype on performance of the limiting antigen-avidity enzyme immunoassay, the bio-rad avidity assay, and the BED capture immunoassay in Rakai, Uganda.

Authors:  Andrew F Longosz; David Serwadda; Fred Nalugoda; Godfrey Kigozi; Veronica Franco; Ronald H Gray; Thomas C Quinn; Susan H Eshleman; Oliver Laeyendecker
Journal:  AIDS Res Hum Retroviruses       Date:  2013-10-25       Impact factor: 2.205

3.  Development of two avidity-based assays to detect recent HIV type 1 seroconversion using a multisubtype gp41 recombinant protein.

Authors:  Xierong Wei; Xin Liu; Trudy Dobbs; Debra Kuehl; John N Nkengasong; Dale J Hu; Bharat S Parekh
Journal:  AIDS Res Hum Retroviruses       Date:  2010-01       Impact factor: 2.205

4.  A new general biomarker-based incidence estimator.

Authors:  Reshma Kassanjee; Thomas A McWalter; Till Bärnighausen; Alex Welte
Journal:  Epidemiology       Date:  2012-09       Impact factor: 4.822

5.  Longitudinal data analysis for discrete and continuous outcomes.

Authors:  S L Zeger; K Y Liang
Journal:  Biometrics       Date:  1986-03       Impact factor: 2.571

6.  HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads.

Authors:  Jared M Baeten; Bhavna Chohan; Ludo Lavreys; Vrasha Chohan; R Scott McClelland; Laura Certain; Kishorchandra Mandaliya; Walter Jaoko; Julie Overbaugh
Journal:  J Infect Dis       Date:  2007-03-02       Impact factor: 5.226

7.  Cross-sectional HIV incidence estimation in HIV prevention research.

Authors:  Ron Brookmeyer; Oliver Laeyendecker; Deborah Donnell; Susan H Eshleman
Journal:  J Acquir Immune Defic Syndr       Date:  2013-07       Impact factor: 3.731

8.  Differential specificity of HIV incidence assays in HIV subtypes A and D-infected individuals from Rakai, Uganda.

Authors:  Caroline E Mullis; Supriya Munshaw; Mary K Grabowski; Susan H Eshleman; David Serwadda; Ronald Brookmeyer; Fred Nalugoda; Godfrey Kigozi; Joseph Kagaayi; Aaron A R Tobian; Maria Wawer; Ronald H Gray; Thomas C Quinn; Oliver Laeyendecker
Journal:  AIDS Res Hum Retroviruses       Date:  2013-05-29       Impact factor: 2.205

9.  Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies.

Authors:  Yen T Duong; Maofeng Qiu; Anindya K De; Keisha Jackson; Trudy Dobbs; Andrea A Kim; John N Nkengasong; Bharat S Parekh
Journal:  PLoS One       Date:  2012-03-27       Impact factor: 3.240

10.  Development of methods for cross-sectional HIV incidence estimation in a large, community randomized trial.

Authors:  Oliver Laeyendecker; Michal Kulich; Deborah Donnell; Arnošt Komárek; Marek Omelka; Caroline E Mullis; Greg Szekeres; Estelle Piwowar-Manning; Agnes Fiamma; Ronald H Gray; Tom Lutalo; Charles S Morrison; Robert A Salata; Tsungai Chipato; Connie Celum; Erin M Kahle; Taha E Taha; Newton I Kumwenda; Quarraisha Abdool Karim; Vivek Naranbhai; Jairam R Lingappa; Michael D Sweat; Thomas Coates; Susan H Eshleman
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

View more
  12 in total

1.  Validation of the Limiting Antigen Avidity Assay to Estimate Level and Trends in HIV Incidence in an A/D Epidemic in Rakai, Uganda.

Authors:  Oliver Laeyendecker; Ronald H Gray; M Kate Grabowski; Steven J Reynolds; Anthony Ndyanabo; Joseph Ssekasanvu; Reinaldo E Fernandez; Maria J Wawer; David Serwadda; Thomas C Quinn
Journal:  AIDS Res Hum Retroviruses       Date:  2019-01-29       Impact factor: 2.205

2.  Cross-sectional HIV incidence estimation in an evolving epidemic.

Authors:  Doug Morrison; Oliver Laeyendecker; Ron Brookmeyer
Journal:  Stat Med       Date:  2019-05-21       Impact factor: 2.373

3.  Short Communication: False Recent Ratio of the Limiting-Antigen Avidity Assay and Viral Load Testing Algorithm Among Cameroonians with Long-Term HIV Infection.

Authors:  Briana A Lynch; Eshan U Patel; Colleen R Courtney; Aubin J Nanfack; Jude Bimela; Xiaohong Wang; Issa Eid; Thomas C Quinn; Oliver Laeyendecker; Phillipe N Nyambi; Ralf Duerr; Andrew D Redd
Journal:  AIDS Res Hum Retroviruses       Date:  2017-08-07       Impact factor: 2.205

4.  Impact of Early Antiretroviral Treatment Initiation on Performance of Cross-Sectional Incidence Assays.

Authors:  Ethan Klock; George Mwinnya; Leigh Anne Eller; Reinaldo E Fernandez; Hannah Kibuuka; Sorachai Nitayaphan; Josphat Kosgei; Richard D Moore; Merlin Robb; Susan H Eshleman; Oliver Laeyendecker
Journal:  AIDS Res Hum Retroviruses       Date:  2020-05-27       Impact factor: 2.205

5.  Estimating HIV Incidence Using a Cross-Sectional Survey: Comparison of Three Approaches in a Hyperendemic Setting, Ndhiwa Subcounty, Kenya, 2012.

Authors:  Stéphanie Blaizot; Andrea A Kim; Clement Zeh; Benjamin Riche; David Maman; Kevin M De Cock; Jean-François Etard; René Ecochard
Journal:  AIDS Res Hum Retroviruses       Date:  2016-12-13       Impact factor: 2.205

6.  Computational analysis of antibody dynamics identifies recent HIV-1 infection.

Authors:  Kelly E Seaton; Nathan A Vandergrift; Aaron W Deal; Wes Rountree; John Bainbridge; Eduard Grebe; David A Anderson; Sheetal Sawant; Xiaoying Shen; Nicole L Yates; Thomas N Denny; Hua-Xin Liao; Barton F Haynes; Merlin L Robb; Neil Parkin; Breno R Santos; Nigel Garrett; Matthew A Price; Denise Naniche; Ann C Duerr; Sheila Keating; Dylan Hampton; Shelley Facente; Kara Marson; Alex Welte; Christopher D Pilcher; Myron S Cohen; Georgia D Tomaras
Journal:  JCI Insight       Date:  2017-12-21

7.  Sensitive Next-Generation Sequencing Method Reveals Deep Genetic Diversity of HIV-1 in the Democratic Republic of the Congo.

Authors:  Mary A Rodgers; Eduan Wilkinson; Ana Vallari; Carole McArthur; Larry Sthreshley; Catherine A Brennan; Gavin Cloherty; Tulio de Oliveira
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

8.  The concordance of the limiting antigen and the Bio-Rad avidity assays in persons from Estonia infected mainly with HIV-1 CRF06_cpx.

Authors:  Kristi Huik; Pilleriin Soodla; Merit Pauskar; S Michele Owen; Wei Luo; Gary Murphy; Ene-Ly Jõgeda; Eveli Kallas; Heli Rajasaar; Radko Avi; Silvina Masciotra; Irja Lutsar
Journal:  PLoS One       Date:  2019-05-24       Impact factor: 3.240

9.  Identifying Risk Factors for Recent HIV Infection in Kenya Using a Recent Infection Testing Algorithm: Results from a Nationally Representative Population-Based Survey.

Authors:  Andrea A Kim; Bharat S Parekh; Mamo Umuro; Tura Galgalo; Rebecca Bunnell; Ernest Makokha; Trudy Dobbs; Patrick Murithi; Nicholas Muraguri; Kevin M De Cock; Jonathan Mermin
Journal:  PLoS One       Date:  2016-05-19       Impact factor: 3.240

10.  Identification and validation of a multi-assay algorithm for cross-sectional HIV incidence estimation in populations with subtype C infection.

Authors:  Oliver Laeyendecker; Jacob Konikoff; Douglas E Morrison; Ronald Brookmeyer; Jing Wang; Connie Celum; Charles S Morrison; Quarraisha Abdool Karim; Audrey E Pettifor; Susan H Eshleman
Journal:  J Int AIDS Soc       Date:  2018-02       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.